Immunotherapy of head and neck cancer: current and future considerations.
about
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisNovel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.Oral epithelial stem cells - implications in normal development and cancer metastasis.Immunological treatment options for locoregionally advanced head and neck squamous cell carcinomaIRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis.Epidemiology and clinical aspects of HPV in head and neck cancers.High-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli.Mononuclear phagocytes in head and neck squamous cell carcinoma.The clinical implications of antitumor immunity in head and neck cancer.Immunotherapy for head and neck cancer patients: shifting the balance.Immune alterations and immunotherapy prospects in head and neck cancer.The interplay between HPV and host immunity in head and neck squamous cell carcinoma.The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.PPARγ targeted oral cancer treatment and additional utility of genomics analytic techniques.Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy.Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancerTherapeutic vaccines for high-risk HPV-associated diseases.Detection of MAGE-A expression predicts malignant transformation of oral leukoplakia.
P2860
Q28388257-5B0E25E1-129D-4A3B-AB74-2CDF3ED39ABAQ33772810-ECC31268-91B1-4DDE-8DA0-8875CFE002F3Q34147649-CBC25398-C3FA-4D6C-AB00-08A049069AC2Q34181954-38AF2868-3CEC-45C5-91D8-9F2FDD63E0F2Q34585798-DD872AC8-2B61-44AB-A657-0297FC221C73Q35575766-9D3E292C-7496-4973-8E7C-232F24BC3C2DQ36088074-FBBCB8DB-59B9-45AB-B5FC-BD18747E42C3Q37283860-EDE86AD5-6F4B-4F89-80A5-34E04ED0046FQ37646333-B8099FB1-355B-4A5E-9906-9F42052BE0CFQ37970005-64FDE0D7-7243-4D10-8B1B-FAF17A15064EQ38068966-5CBA71C5-DACE-4F34-AA5C-7EB9CC8F14BCQ38116067-1D009F8E-7B3A-4A53-AB8A-08890F733D20Q38126455-7C18E43A-3F38-477B-8665-FA0A39721FE1Q38161874-B4192700-B7E6-4ADF-A122-5A0767038C8DQ38728448-79E31865-3961-48D5-8325-A02E473E1E48Q38817649-27DC902B-8CAF-45EF-AEB1-D9F954E67544Q39328588-D1D5ACD8-AEE6-44D9-9AD4-670BF51A10E8Q41819835-9E492403-C12D-4811-B160-95560AFAF7DBQ47255618-8B67790B-C03F-44A9-8C86-D3274BF4295FQ53269756-8DA93A53-2B91-40B1-B181-087166784034
P2860
Immunotherapy of head and neck cancer: current and future considerations.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Immunotherapy of head and neck cancer: current and future considerations.
@en
Immunotherapy of head and neck cancer: current and future considerations.
@nl
type
label
Immunotherapy of head and neck cancer: current and future considerations.
@en
Immunotherapy of head and neck cancer: current and future considerations.
@nl
prefLabel
Immunotherapy of head and neck cancer: current and future considerations.
@en
Immunotherapy of head and neck cancer: current and future considerations.
@nl
P2860
P356
P1433
P1476
Immunotherapy of head and neck cancer: current and future considerations.
@en
P2093
Alexander D Rapidis
Gregory T Wolf
P2860
P304
P356
10.1155/2009/346345
P577
2009-08-09T00:00:00Z